Literature DB >> 8111538

Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy.

J M Ervasti1, K P Campbell.   

Abstract

Dystrophin constitutes approximately 5% of the cytoskeletal protein of skeletal muscle sarcolemma, suggesting that dystrophin could play a major structural role in skeletal muscle. We have presented evidence for the existence of a large oligomeric complex containing dystrophin, a 59 kDa triplet, a 25 kDa protein and four sarcolemmal glycoproteins with apparent M(r) of 156 kDa, 50 kDa, 43 kDa and 35 kDa. All components of the dystrophin-glycoprotein complex were localized to the skeletal muscle sarcolemma. Dystrophin, the 156 kDa and 59 kDa dystrophin-associated protein were found to be peripheral membrane proteins while the 50 kDa, 43 kDa, 35 kDa and 25 kDa dystrophin-associated proteins were confirmed as integral membrane proteins. The primary sequences of the 43 kDa and 156 kDa dystrophin-associated glycoproteins have been established by recombinant DNA techniques. Both the 43 and 156 kDa dystrophin-associated glycoproteins are encoded by a single 5.8 kb mRNA which is expressed in a variety of tissues in addition to skeletal muscle. The 156 kDa dystrophin-associated glycoprotein binds laminin, a well characterized component of the extracellular matrix. Finally, the dystrophin-glycoprotein complex is specifically and greatly reduced in Duchenne-afflicted and mdx mouse skeletal muscle, suggesting that the loss of dystrophin-associated proteins is due to the absence of dystrophin and not due to secondary effects of muscle fibre degradation. Taken together, these data support the hypothesis that the absence of dystrophin leads to a loss of the linkage between the subsarcolemmal cytoskeleton and extracellular matrix and that this may initiate muscle fibre necrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111538     DOI: 10.1007/978-94-011-1528-5_6

Source DB:  PubMed          Journal:  Mol Cell Biol Hum Dis Ser        ISSN: 1470-0573


  28 in total

1.  The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins.

Authors:  Patrice Fort; Francisco-Javier Estrada; Agnès Bordais; Dominique Mornet; José-Alain Sahel; Serge Picaud; Haydeé Rosas Vargas; Ramón M Coral-Vázquez; Alvaro Rendon
Journal:  Neurosci Res       Date:  2005-09       Impact factor: 3.304

Review 2.  Mechanotransduction in cardiac hypertrophy and failure.

Authors:  Robert C Lyon; Fabian Zanella; Jeffrey H Omens; Farah Sheikh
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

3.  Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Authors:  Sébastien Goudenege; Yann Lamarre; Nicolas Dumont; Joël Rousseau; Jérôme Frenette; Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-03       Impact factor: 11.454

4.  Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.

Authors:  Daniel P Reay; Gabriela A Niizawa; Jon F Watchko; Molly Daood; Ja'Nean C Reay; Eugene Raggi; Paula R Clemens
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

5.  Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Authors:  Katharine M Sharpe; Monica D Premsukh; DeWayne Townsend
Journal:  J Muscle Res Cell Motil       Date:  2013-10-06       Impact factor: 2.698

6.  Dystroglycan and protein O-mannosyltransferases 1 and 2 are required to maintain integrity of Drosophila larval muscles.

Authors:  Nicola Haines; Sara Seabrooke; Bryan A Stewart
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

7.  New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy.

Authors:  Rosário Santos; Ana Gonçalves; Jorge Oliveira; Emília Vieira; José Pedro Vieira; Teresinha Evangelista; Teresa Moreno; Manuela Santos; Isabel Fineza; Elsa Bronze-da-Rocha
Journal:  J Hum Genet       Date:  2014-07-10       Impact factor: 3.172

8.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

9.  Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency.

Authors:  H Kawai; M Akaike; T Endo; K Adachi; T Inui; T Mitsui; S Kashiwagi; T Fujiwara; S Okuno; S Shin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  The costamere bridges sarcomeres to the sarcolemma in striated muscle.

Authors:  Angela K Peter; Hongqiang Cheng; Robert S Ross; Kirk U Knowlton; Ju Chen
Journal:  Prog Pediatr Cardiol       Date:  2011-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.